FREE CLAIM EVALUATION
CONTACT US AT (866) 495-5189
The law firm of Milberg LLP is pursuing litigation against Boston Scientific and Cordis Corporation, a Johnson & Johnson company, related to the implantation of medicated coronary stent devices.
On September 14, 2006, the FDA released a Statement in response to inquiries asking for the agency’s position on adverse events related to Coronary Drug-Eluting Stents (DES). The FDA confirmed that it was aware of recent data suggesting a significant increase in the rate of death and myocardial infarction (heart attack) possibly due to stent thrombosis (a blood clot in the stent) in patients treated with DES.
Stents are small, expandable, stainless steel tubes used to prop open and offer support to arteries that would otherwise be collapsing. The CYPHER® and TAXUS® Stents are drug eluting stents (DES), also known as medicated stents. Unlike bare metal stents they are coated in medications intended to prevent restenosis (reblocking of the artery). Medicated stents are increasingly common, representing approximately 90% of all stents sold in the U.S. in recent years.
Since the CYPHER® Sirolimus-eluting stent first received approval for use on April 24, 2003 and the TAXUS® Express Paclitaxel-eluting stent received approval for use by the FDA on March 4, 2004, over 1.5 million CYPHER® stents have been implanted in patients worldwide and over 3 million TAXUS® stents have been implanted in patients worldwide for treatment of coronary artery disease. This has generated $5 billion in sales revenue to the manufacturers.
Recent studies have linked medicated stents with side effects such as thrombosis (blood clotting) and the need for long-term costly antiplatelet medication therapy in order to prevent thrombosis. The studies also found that the drug-coated stents may result in a higher death rate due to cardiac events such as heart attack when compared to metal stents without a drug coating.
If you or a loved one has suffered injuries or have legal concerns related to these products, please contact us via our Free Claim Evaluation or via (866) 495-5189 or via this Contact Us link. You may be legally entitled to recover medical expenses, lost earnings, as well as compensation for physical pain and suffering, mental anguish and physical impairment. For persons who have died, their surviving spouse or other family members often can bring a wrongful death action.
Milberg LLP
One Pennsylvania Plaza, 49th Fl.
New York, NY, 10119-0165
Phone number: (866) 495-5189
Email: contactus@milberg.com
Website: http://www.milberg.com
ATTORNEY ADVERTISING
PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME
|
|
